The use of both datasets achieved a unified result; Kaplan-Meier survival analysis revealed that colon cancer patients with lower TNK2 expression had better prognoses than those with higher TNK2 expression (Figures 4A,B). This evidence concerns the gene TNK2 and malignant colon neoplasm.